
Dan Bell, chief strategy officer at Marken, discusses how biopharma companies and logistics teams are responding to the dual disruptors to global supply chain operations.
Chief strategy officer with Marken UPS Healthcare Precision Logistics. Bell joined legacy Marken in 2003. He is a licensed US Customs Broker and a certified customs specialist with more than 26 years of experience in the life science logistics and temperature control field.
Bell is responsible for leading the strategy, marketing, and pricing teams at Marken, UPS Healthcare Precision Logistics, with a focus on finding new ways to innovate, optimize, and solve clients’ greatest challenges. He has served as a liaison between clients, customs, and the alphabet soup of regulatory agencies to ensure the maximum level of compliance with trade laws and regulations.
As regulatory scrutiny continues to focus on the temperature-controlled supply chain, Bell’s expertise with thermoregulating packaging solutions and temperature logging devices has been critical to meeting the requirements of the recently updated Good Distribution Practices for pharmaceutical transport and similar guidelines.